Odyssey Therapeutics IPO

Biotech company develops innovative treatments for autoimmune and inflammatory diseases by targeting immune system signaling pathways.

NASDAQ: ODTX

Buy

Buy Private Stock

Sign up to invest in private companies like Odyssey Therapeutics before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Odyssey Therapeutics before their IPO.

Overview

Odyssey Therapeutics completed their IPO on May 8, 2026. Now that Odyssey Therapeutics is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.

Odyssey Therapeutics is a biotechnology company focused on developing innovative treatments for autoimmune and inflammatory diseases. By targeting upstream signaling nodes within the innate immune system, the company aims to prevent pathological inflammation before it starts, offering the potential for long-lasting and deep remission. Their pipeline includes small molecule and protein therapeutics designed to precisely address disease pathology, prioritizing conditions with significant unmet needs.

Sector

Healthcare & Life Sciences

Founded

2021

Headquarters

Boston, MA

Buy

Buy Private Stock

Sign up to invest in private companies like Odyssey Therapeutics before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Odyssey Therapeutics before their IPO.

Odyssey Therapeutics Management Team

Odyssey Therapeutics people and management – Prior to IPO

  • Board Member
    Jill Carroll

Investors

Major Odyssey Therapeutics investors

  • Ascenta Capital

  • Foresite Capital

  • OrbiMed Advisors

  • SR One Capital Management

  • General Catalyst

  • Woodline Partners

Odyssey Therapeutics Valuations & Financials

Looking for private company valuations and share price data?

Nasdaq Private Market Data & Intelligence is the private company valuation database covering 4,000+ venture-backed companies with daily pricing, financing history, and secondary market activity. View real-time NPM data on pre-IPO companies including valuations, private company comparable transactions, and historical share price information — the private company due diligence data sources institutional investors rely on.

Similar Companies

Explore companies

like Odyssey Therapeutics

  • Cerebral

    Healthcare & Life Sciences

    Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

  • Devoted Health

    Healthcare & Life Sciences

    Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

  • Roman Health Ventures-Logo

    Ro

    Healthcare & Life Sciences

    Healthcare technology for a patient-centric healthcare system.

  • Virta Health-Logo

    Virta Health

    Healthcare & Life Sciences

    Online specialty medical clinic focused on reversing type 2 diabetes.

  • Somatus-Logo

    Somatus

    Healthcare & Life Sciences

    Integrated care for patients with or at risk of developing kidney disease.

  • Color-Logo

    Color

    Healthcare & Life Sciences

    Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

  • Cedar Inc-Logo

    Cedar

    Healthcare & Life Sciences

    The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

  • Eikon Therapeutics Inc-Logo

    Eikon Therapeutics

    Healthcare & Life Sciences

    Uses revolutionary technology to discover novel treatments for life-threatening diseases.

  • OpenEvidence

    Healthcare & Life Sciences

    Empowers clinicians who seek evidence‑based insights by delivering AI‑summarized medical research at the point of care.

FAQ

Questions?

We have answers

Buy Odyssey Therapeutics Stock

Odyssey Therapeutics became publicly traded following its IPO on May 8, 2026, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: ODTX. Before the IPO, Odyssey Therapeutics stock was privately held and available only through private market transactions.

If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.

Sell Odyssey Therapeutics Stock

Following its IPO on May 8, 2026, Odyssey Therapeutics shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.

If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.

 

Odyssey Therapeutics Stock Price

Following the IPO, Odyssey Therapeutics stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching Odyssey Therapeutics’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.

Odyssey Therapeutics Stock Ticker Symbol

Following its IPO on May 8, 2026, Odyssey Therapeutics stock now trades on public markets under the ticker symbol NASDAQ: ODTX. You can view real-time stock information through widely used financial data platforms.

Criteria to Sell Odyssey Therapeutics Stock

Following the Odyssey Therapeutics IPO, public shares can be sold through any brokerage.

Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Odyssey Therapeutics Stock

Following Odyssey Therapeutics’s initial public offering on May 8, 2026, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying Odyssey Therapeutics stock can do so through their preferred broker, just as they would with any other publicly traded security.

Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Odyssey Therapeutics Stock Settlement

Since Odyssey Therapeutics is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.

Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Odyssey Therapeutics IPO

Odyssey Therapeutics completed its IPO on May 8, 2026, and is now publicly available through major financial sources.